NCT05477797View on ClinicalTrials.gov

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.

NARecruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

February 16, 2023

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2026

Conditions
Progression Free SurvivalOverall SurvivalMaintenance
Interventions
DRUG

Ixazomib DX/Lenalidomide DX

After assessment of risk stratification，patients will be assigned to Id or Rd group randomly for maintenance therapy. Then they will be reviewed the efficacy monthly.

Trial Locations (1)

Unknown

RECRUITING

shanghai Jiaotong University School of Medicine, Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER